Liver kinome reveals PS1145 as therapeutic agent for mitigating systemic inflammation in alcohol-related liver disease - 04/02/26
Abstract |
Rationale |
Alcohol-related liver disease (ALD) lacks effective anti-inflammatory therapies, and since kinases orchestrate inflammation, kinome profiling offers a rational approach to identify and validate novel therapeutic targets.
Objective |
To analyse liver and monocyte kinome alterations in a chronic ethanol-fed pre-clinical rat model and identify therapeutic targets capable of mitigating inflammation. Pathway-specific inhibitors, including PS1145 (IKK-phosphorylation-inhibitor), PH797804 (MAPK14-inhibitor), resveratrol, and prednisolone were evaluated in ALD-rats, PBMCs from patients, and the NIAAA mouse model.
Findings |
Kinome profiling identified 497 hepatic and 345 monocyte kinases in ALD rats (FDR<0.01), with a time-dependent increase in MAPK14-associated kinases in both tissues (FC>1.5, p < 0.05). By 24 weeks, 172-liver and 48-monocyte kinases were upregulated, primarily involving MyD88-TLR4, PI3K-Akt, TNF, TGFβ-TGFβR1, senescence and ROS-generating kinases and IL-1-driven MAPK14 and IKK phosphorylation(p < 0.05). Targeting this axis, PS1145 suppressed NFκB activation and inflammation in THP1, HepG2 cells, PBMCs from healthy and SAH-patients, outperforming PH797804, resveratrol, and prednisolone (FC>1.5,p < 0.05). PS1145 significantly reduced IL-6, TNFα, and NFκB, while increasing IL-10. In NIAAA-mouse model, PS1145 treatment reduced hepatic steatosis, cellular stress, and inflammation, IL36R disrupting TLR dimerization more effectively than standard therapies (p < 0.05).
Conclusion |
PS1145 blocks IKK phosphorylation and TLR dimerization, attenuating inflammation and improving liver pathology, highlighting its therapeutic potential in ALD.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Kinome profiling identified IKK phosphorylation as a therapeutic target for controlling systemic inflammation in alcohol-associated liver disease (ALD). Pharmacological inhibition of IKK-phosphorylation using PS1145 effectively ameliorated alcohol-induced liver injury by preventing NF-κB activation through retention of the NF-κB complex in the cytoplasm. PS1145 treatment also downregulated IL-36 receptor expression, thereby attenuating TLR4-driven inflammatory signaling in the liver. Together, these findings demonstrate that targeted inhibition of IKK phosphorylation can suppress maladaptive NF-κB and IL-36R/TLR4 pathways, offering a promising strategy for mitigating systemic inflammation in ALD.
Kinome profiling identified IKK phosphorylation as a therapeutic target for controlling systemic inflammation in alcohol-associated liver disease (ALD). Pharmacological inhibition of IKK-phosphorylation using PS1145 effectively ameliorated alcohol-induced liver injury by preventing NF-κB activation through retention of the NF-κB complex in the cytoplasm. PS1145 treatment also downregulated IL-36 receptor expression, thereby attenuating TLR4-driven inflammatory signaling in the liver. Together, these findings demonstrate that targeted inhibition of IKK phosphorylation can suppress maladaptive NF-κB and IL-36R/TLR4 pathways, offering a promising strategy for mitigating systemic inflammation in ALD. Le texte complet de cet article est disponible en PDF.
Highlights |
• | Kinome profiling of liver and monocytes identified targets for controlling systemic inflammation in ALD. |
• | IKK, an NFκB activator, was identified as a potential therapeutic target. |
• | Blocking IKK phosphorylation retains IKK in cytoplasm, limiting NFκB inflammation. |
• | PS1145, an IKK inhibitor, reduced systemic inflammation via IKKp and IL36R reduction. |
Abbreviations : ALD, SAH, AST, ALT, ROS, LDC, LE, MTOR, MAPK14, NFkB, IL6, TNFa, IL10, FC
Keywords : Phosphoproteomics, Alcohol-related Liver Disease, Kinome signaling, inflammation, PS1145, PH787904, Prednisolone, pre-clinical ALD Rat model
Plan
Vol 195
Article 118984- février 2026 Retour au numéro
Article précédent
- As a novel ferroptosis inhibitor, primaquine alleviates I/R-induced retinal neuron death via increasing GSTA1 activity
- Shuang Lu, Lewen Wang, Keting Wang, Kun Xiong, Weitao Yan
- High leptin levels independent of body mass index are associated with inflammation and poorer treatment response in patients with diffuse large B-cell lymphoma
- Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, Carlos Jiménez-Cortegana, Esteban Nogales-Fernández, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Eduardo Ríos-Herranz, Josep Gumà-Padrò, Mariano Provencio-Pulla, Antonio Rueda-Domínguez, Luis de la Cruz-Merino, Víctor Sánchez-Margalet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?